Navigation Links
Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
Date:11/9/2009

ALISO VIEJO, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make presentations at two upcoming investor conferences in New York City.

The first presentation will be made at the Lazard Capital Markets Sixth Annual Healthcare Conference at 1:40 pm EST on Tuesday, November 17. The conference will be held at the St. Regis Hotel November 17-18.

The second presentation will be made at the 21st Annual Piper Jaffray Health Care Conference at 10:30 am EST on Wednesday, December 2. The conference will be held at the New York Palace Hotel December 1-2.

Live webcasts of the Company's presentations at the conferences will be available via a link provided at http://www.clarientinc.com/investor. Archived replays of the presentations will also be available shortly after the presentation time for a period of at least 60 days.

About Clarient

Clarient combines innovative diagnostic technologies with world-class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by collaborating with the healthcare community to translate cancer research and development into better patient care. Clarient's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. The rise of individualized medicine has created the need for a centralized resource which provides leading oncology diagnostic technologies, such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory, which provides the most advanced oncology testi
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015  Today, in final recognition ... Contact Lens Health Week, 1-800 Contacts is sharing how ... that contact lens wearers who do not properly care ... for eye infections. Most contact lens ... but a clean lens case is sometimes overlooked.  When ...
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3
... 30 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced today that ... close of the market on Wednesday May 5, 2010 . , ... Paul Hamelin , R.Ph., President and ... community conference call beginning at 10:00 a.m. Eastern Time on ...
... 30 World Heart Corporation (WorldHeart; Nasdaq: ... the appointment of Dr. John Campbell Woodard as ... responsible for clinical affairs and will also guide the development ... served as Chief Scientific Officer for Ventracor Limited: an Australian-based ...
Cached Medicine Technology:Savient Pharmaceuticals To Hold First Quarter 2010 Results 2WorldHeart Appoints Dr. John Campbell Woodard as Senior Vice President of Scientific Affairs 2WorldHeart Appoints Dr. John Campbell Woodard as Senior Vice President of Scientific Affairs 3
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of ... for the position they are applying for, they are unable to pass the initial ... considering altering drug testing policies in order to be able to hire long-term, skilled ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Medical Devices:, Understanding the FDA’s Position and Best Practices for Compliance, **Presented ... , This workshop, chaired by internationally renowned expert Fubin Wu, has ...
(Date:8/28/2015)... ... August 28, 2015 , ... Loved ones of a person ... with chemical dependency, may be able to find some hope in the latest ... center for addiction located in Western Michigan. Focusing on several different aspects of ...
(Date:8/28/2015)... Boynton Beach, FL. (PRWEB) , ... August 28, ... ... creating problems for businesses nationwide. Addictions specialist, Dr. James Strawbridge, gives a new ... Strawbridge believes that it should begin with the employer and employees getting together ...
(Date:8/28/2015)... ... , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with ... pain, hip pain, neck pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan ... then went on to earn his title of Doctor of Chiropractic from the Palmer ...
Breaking Medicine News(10 mins):Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3
... Only about a third of American women are ... means they are likely missing out on potentially important ... minerals and fiber, fruits and vegetables contain a type ... women,s health including breast and ovarian health. ...
... Madonna Behen HealthDay Reporter , TUESDAY, Oct. ... help doctors one day identify which patients with mild ... Swiss researchers report. Using a combination of specialized ... University Hospitals of Geneva said they were able to ...
... Medical tourism is to go under the microscope in a ... of York, which aims to assess its potential advantages and ... Institute for Health Research , will examine the motives people ... as dental services, elective surgery for hip or joint replacement, ...
... HealthDay Reporter , MONDAY, Oct. 4 (HealthDay News) -- ... the long-term than individual counseling, a new study finds. ... the treatment of anorexia nervosa for maybe 40 years, but ... treatment for the last 10," said Dr. James Lock, lead ...
... of chronic diseases to the top of the EU ... Kidney Health , the EU Diabetes Working Group and ... the European Parliament, together with representatives of health professionals and ... these chronic diseases urgently, they threaten the "Europe 2020 strategy", ...
... Using advanced MRI and an artificial intelligence technique, ... may help identify which individuals with mild cognitive impairment ... published online and in the December issue of ... all individuals with early-stage mild cognitive impairment will progress ...
Cached Medicine News:Health News:Shortfalls in carotenoid intake may impact women's health 2Health News:Shortfalls in carotenoid intake may impact women's health 3Health News:Shortfalls in carotenoid intake may impact women's health 4Health News:Computer-Aided MRI Might Help Predict Alzheimer's 2Health News:Computer-Aided MRI Might Help Predict Alzheimer's 3Health News:Traveling for treatment: The case for and against 2Health News:Anorexic Teens May Gain From Whole-Family Treatment 2Health News:Anorexic Teens May Gain From Whole-Family Treatment 3Health News:Heart, kidney, diabetes and cancer MEP groups league against chronic disease to seek European commitment 2Health News:Heart, kidney, diabetes and cancer MEP groups league against chronic disease to seek European commitment 3Health News:MRI may predict continued decline in patients with mild cognitive impairment 2
... test combines performance equivalence to 14-day viral culture ... B with a simple, easy-to-use test with results ... all the same procedural steps as our FLU ... decrease costs for unnecessary ancillary testing, improve appropriate ...
... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...
Shielding's Flex Back Apron is one of our most popular. Similar to the Velcro Adjustable but with elastic back panels for additional support and comfort....
Shielding's Standard Coat Apron with open back allows for freedom of movement, maximum flexibility and increased comfort....
Medicine Products: